About this trial
A randomized controlled trial was conducted to compare the treatment efficacy of iRoot SP and nRoot SP Root Canal Sealer Materials in patients with chronic apical periodontitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years.
Diagnosis of apical periodontitis conforming to the diagnostic criteria in Endodontics.
The affected tooth is deemed restorable upon evaluation, with non-vital pulp requiring extirpation.
The affected tooth is a single tooth with a fully developed apical foramen.
Disqualifiers
Patients with alveolar bone loss exceeding one-third of the root length.
Affected teeth with root fracture, root canal obstruction, calcification, or root surface caries.
Patients with severe systemic diseases (e.g., osteoporosis, mental disorders, hepatic or renal insufficiency).
Patients who have taken analgesics, immunosuppressants, or antibiotics within one week prior to enrollment.
Trial design
Parallel
Treatments tested in this trial
iRoot SP
Deviceuse iRoot SP in root canal treatment
nRoot SP
Deviceuse nRoot SP in root canal treatment
Treatment groups
Trial outcomes
Primary outcomes
therapeutic effect
Markedly Effective: Post-treatment X-ray examination shows complete resolution of the periapical radiolucency. The patient's chewing function is largely restored, and symptoms such as gingival swelling/pain, tooth discoloration, and occlusal discomfort have disappeared. Effective: Post-treatment X-ray examination shows significant reduction in the size of the radiolucency. The patient may experience mild percussion pain or discomfort. Chewing function is largely normal, and symptoms such as gingival swelling/pain, tooth discoloration, and occlusal discomfort show improvement. Ineffective: Post-treatment X-ray examination shows no reduction or even enlargement of the radiolucency. The patient reports significant percussion pain. Symptoms such as gingival swelling/pain, tooth discoloration, and occlusal discomfort show no improvement.
Secondary outcomes
clinical manifestation
Four distinct clinical assessments to be evaluated at 3, 6, 12, and 24 months postoperatively: tooth mobility, assessed clinically using a standard grading scale (Miller index. Grade I: Mobility with a buccolingual displacement of ≤1 mm; Grade II: Mobility with a buccolingual displacement of 1-2 mm, possibly accompanied by slight mesiodistal mobility; Grade III: Mobility with a buccolingual or mesiodistal displacement exceeding 2 mm, or the presence of vertical mobility.) ; periodontal probing depth, measured at designated sites(mesiobuccal, midbuccal, distobuccal mesiolingual, midlingual, distolingual).) around the tooth with a periodontal probe and recorded in millimeters; percussion pain, evaluated by vertical and horizontal tapping and documented either as a binary presence/absence; the presence of a sinus tract, determined through visual inspection and verification with a gutta-percha point if necessary and recorded as a binary outcome. Each parameter will be analyzed independent
Imaging findings
Change in the size of the periapical radiolucent area. Specifically, after acquiring the image, the DICOM format image will be imported into 3D slicer, the maximum diameter of the apical low-density shadow will be measured using the ruler function, the range of the apical low-density shadow will be divided using the segment editor module, and the volume of the periapical shadow will be calculated using the segment statistics module
Sponsors and contacts
Click on the lead sponsor to view all of their trials.